カテゴリー： QYResearch, 世界

世界の泌尿生殖器治療市場規模・現状・予測2021-2027

【英語タイトル】Global Treatment for Genito-Urinary Market Size, Status and Forecast 2021-2027
	・商品コード：QY21APR5739 ・発行会社（調査会社）：QYResearch ・発行日：2021年4月・ページ数：99 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール（受注後3営業日）・調査対象地域：グローバル・産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥518,700	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥778,050	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

本調査資料では、泌尿生殖器治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx治療薬）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・泌尿生殖器治療の市場動向
・企業の競争状況、市場シェア
・泌尿生殖器治療の種類別市場規模（OTC、Rx治療薬）
・泌尿生殖器治療の用途別市場規模（病院、ドラッグストア、その他）
・泌尿生殖器治療の北米市場規模2016-2027（アメリカ、カナダ）
・泌尿生殖器治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・泌尿生殖器治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・泌尿生殖器治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・泌尿生殖器治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Daiichi Sankyo Company、Pfizer、Bayer、Astellas Pharma、Allergan、GSK、Otsuka Pharmaceutical、Sanofi）
・結論

【レポートの概要】

Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).

Market Analysis and Insights: Global Treatment for Genito-Urinary Market
The global Treatment for Genito-Urinary market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment for Genito-Urinary market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment for Genito-Urinary market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment for Genito-Urinary market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment for Genito-Urinary market.

Global Treatment for Genito-Urinary Scope and Market Size
Treatment for Genito-Urinary market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treatment for Genito-Urinary market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Drugs Store
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
Allergan
GSK
Otsuka Pharmaceutical
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment for Genito-Urinary Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Treatment for Genito-Urinary Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Treatment for Genito-Urinary Market Perspective (2016-2027)
2.2 Treatment for Genito-Urinary Growth Trends by Regions
2.2.1 Treatment for Genito-Urinary Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Treatment for Genito-Urinary Historic Market Share by Regions (2016-2021)
2.2.3 Treatment for Genito-Urinary Forecasted Market Size by Regions (2022-2027)
2.3 Treatment for Genito-Urinary Industry Dynamic
2.3.1 Treatment for Genito-Urinary Market Trends
2.3.2 Treatment for Genito-Urinary Market Drivers
2.3.3 Treatment for Genito-Urinary Market Challenges
2.3.4 Treatment for Genito-Urinary Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Treatment for Genito-Urinary Players by Revenue
3.1.1 Global Top Treatment for Genito-Urinary Players by Revenue (2016-2021)
3.1.2 Global Treatment for Genito-Urinary Revenue Market Share by Players (2016-2021)
3.2 Global Treatment for Genito-Urinary Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Treatment for Genito-Urinary Revenue
3.4 Global Treatment for Genito-Urinary Market Concentration Ratio
3.4.1 Global Treatment for Genito-Urinary Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment for Genito-Urinary Revenue in 2020
3.5 Treatment for Genito-Urinary Key Players Head office and Area Served
3.6 Key Players Treatment for Genito-Urinary Product Solution and Service
3.7 Date of Enter into Treatment for Genito-Urinary Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Treatment for Genito-Urinary Breakdown Data by Type
4.1 Global Treatment for Genito-Urinary Historic Market Size by Type (2016-2021)
4.2 Global Treatment for Genito-Urinary Forecasted Market Size by Type (2022-2027)

5 Treatment for Genito-Urinary Breakdown Data by Application
5.1 Global Treatment for Genito-Urinary Historic Market Size by Application (2016-2021)
5.2 Global Treatment for Genito-Urinary Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Treatment for Genito-Urinary Market Size (2016-2027)
6.2 North America Treatment for Genito-Urinary Market Size by Type
6.2.1 North America Treatment for Genito-Urinary Market Size by Type (2016-2021)
6.2.2 North America Treatment for Genito-Urinary Market Size by Type (2022-2027)
6.2.3 North America Treatment for Genito-Urinary Market Size by Type (2016-2027)
6.3 North America Treatment for Genito-Urinary Market Size by Application
6.3.1 North America Treatment for Genito-Urinary Market Size by Application (2016-2021)
6.3.2 North America Treatment for Genito-Urinary Market Size by Application (2022-2027)
6.3.3 North America Treatment for Genito-Urinary Market Size by Application (2016-2027)
6.4 North America Treatment for Genito-Urinary Market Size by Country
6.4.1 North America Treatment for Genito-Urinary Market Size by Country (2016-2021)
6.4.2 North America Treatment for Genito-Urinary Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Treatment for Genito-Urinary Market Size (2016-2027)
7.2 Europe Treatment for Genito-Urinary Market Size by Type
7.2.1 Europe Treatment for Genito-Urinary Market Size by Type (2016-2021)
7.2.2 Europe Treatment for Genito-Urinary Market Size by Type (2022-2027)
7.2.3 Europe Treatment for Genito-Urinary Market Size by Type (2016-2027)
7.3 Europe Treatment for Genito-Urinary Market Size by Application
7.3.1 Europe Treatment for Genito-Urinary Market Size by Application (2016-2021)
7.3.2 Europe Treatment for Genito-Urinary Market Size by Application (2022-2027)
7.3.3 Europe Treatment for Genito-Urinary Market Size by Application (2016-2027)
7.4 Europe Treatment for Genito-Urinary Market Size by Country
7.4.1 Europe Treatment for Genito-Urinary Market Size by Country (2016-2021)
7.4.2 Europe Treatment for Genito-Urinary Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Treatment for Genito-Urinary Market Size (2016-2027)
8.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type
8.2.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2016-2027)
8.3 Asia-Pacific Treatment for Genito-Urinary Market Size by Application
8.3.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2016-2027)
8.4 Asia-Pacific Treatment for Genito-Urinary Market Size by Region
8.4.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Treatment for Genito-Urinary Market Size (2016-2027)
9.2 Latin America Treatment for Genito-Urinary Market Size by Type
9.2.1 Latin America Treatment for Genito-Urinary Market Size by Type (2016-2021)
9.2.2 Latin America Treatment for Genito-Urinary Market Size by Type (2022-2027)
9.2.3 Latin America Treatment for Genito-Urinary Market Size by Type (2016-2027)
9.3 Latin America Treatment for Genito-Urinary Market Size by Application
9.3.1 Latin America Treatment for Genito-Urinary Market Size by Application (2016-2021)
9.3.2 Latin America Treatment for Genito-Urinary Market Size by Application (2022-2027)
9.3.3 Latin America Treatment for Genito-Urinary Market Size by Application (2016-2027)
9.4 Latin America Treatment for Genito-Urinary Market Size by Country
9.4.1 Latin America Treatment for Genito-Urinary Market Size by Country (2016-2021)
9.4.2 Latin America Treatment for Genito-Urinary Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Treatment for Genito-Urinary Market Size (2016-2027)
10.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type
10.2.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2016-2027)
10.3 Middle East & Africa Treatment for Genito-Urinary Market Size by Application
10.3.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2016-2027)
10.4 Middle East & Africa Treatment for Genito-Urinary Market Size by Country
10.4.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Daiichi Sankyo Company Business Overview
11.1.3 Daiichi Sankyo Company Treatment for Genito-Urinary Introduction
11.1.4 Daiichi Sankyo Company Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.1.5 Daiichi Sankyo Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Treatment for Genito-Urinary Introduction
11.2.4 Pfizer Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Treatment for Genito-Urinary Introduction
11.3.4 Bayer Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Treatment for Genito-Urinary Introduction
11.4.4 Astellas Pharma Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Treatment for Genito-Urinary Introduction
11.5.4 Allergan Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Treatment for Genito-Urinary Introduction
11.6.4 GSK Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.6.5 GSK Recent Development
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Details
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Treatment for Genito-Urinary Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.7.5 Otsuka Pharmaceutical Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Treatment for Genito-Urinary Introduction
11.8.4 Sanofi Revenue in Treatment for Genito-Urinary Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Treatment for Genito-Urinary Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Treatment for Genito-Urinary Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Treatment for Genito-Urinary Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Treatment for Genito-Urinary Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Treatment for Genito-Urinary Market Share by Regions (2016-2021)
Table 8. Global Treatment for Genito-Urinary Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Treatment for Genito-Urinary Market Share by Regions (2022-2027)
Table 10. Treatment for Genito-Urinary Market Trends
Table 11. Treatment for Genito-Urinary Market Drivers
Table 12. Treatment for Genito-Urinary Market Challenges
Table 13. Treatment for Genito-Urinary Market Restraints
Table 14. Global Treatment for Genito-Urinary Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Treatment for Genito-Urinary Market Share by Players (2016-2021)
Table 16. Global Top Treatment for Genito-Urinary Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Genito-Urinary as of 2020)
Table 17. Ranking of Global Top Treatment for Genito-Urinary Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Treatment for Genito-Urinary Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Treatment for Genito-Urinary Product Solution and Service
Table 21. Date of Enter into Treatment for Genito-Urinary Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Treatment for Genito-Urinary Revenue Market Share by Type (2016-2021)
Table 25. Global Treatment for Genito-Urinary Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Treatment for Genito-Urinary Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Treatment for Genito-Urinary Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Treatment for Genito-Urinary Revenue Market Share by Application (2016-2021)
Table 29. Global Treatment for Genito-Urinary Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Treatment for Genito-Urinary Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Treatment for Genito-Urinary Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Treatment for Genito-Urinary Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Treatment for Genito-Urinary Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Treatment for Genito-Urinary Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Treatment for Genito-Urinary Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Treatment for Genito-Urinary Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Treatment for Genito-Urinary Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Treatment for Genito-Urinary Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Treatment for Genito-Urinary Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Treatment for Genito-Urinary Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Treatment for Genito-Urinary Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Treatment for Genito-Urinary Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Treatment for Genito-Urinary Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Treatment for Genito-Urinary Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Treatment for Genito-Urinary Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2022-2027) & (US$ Million)
Table 61. Daiichi Sankyo Company Company Details
Table 62. Daiichi Sankyo Company Business Overview
Table 63. Daiichi Sankyo Company Treatment for Genito-Urinary Product
Table 64. Daiichi Sankyo Company Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 65. Daiichi Sankyo Company Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Treatment for Genito-Urinary Product
Table 69. Pfizer Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Treatment for Genito-Urinary Product
Table 74. Bayer Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Astellas Pharma Company Details
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Treatment for Genito-Urinary Product
Table 79. Astellas Pharma Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 80. Astellas Pharma Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Treatment for Genito-Urinary Product
Table 84. Allergan Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. GSK Company Details
Table 87. GSK Business Overview
Table 88. GSK Treatment for Genito-Urinary Product
Table 89. GSK Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 90. GSK Recent Development
Table 91. Otsuka Pharmaceutical Company Details
Table 92. Otsuka Pharmaceutical Business Overview
Table 93. Otsuka Pharmaceutical Treatment for Genito-Urinary Product
Table 94. Otsuka Pharmaceutical Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 95. Otsuka Pharmaceutical Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Treatment for Genito-Urinary Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment for Genito-Urinary Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Treatment for Genito-Urinary Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Treatment for Genito-Urinary Report Years Considered
Figure 9. Global Treatment for Genito-Urinary Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Treatment for Genito-Urinary Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Treatment for Genito-Urinary Market Share by Regions: 2020 VS 2027
Figure 12. Global Treatment for Genito-Urinary Market Share by Regions (2022-2027)
Figure 13. Global Treatment for Genito-Urinary Market Share by Players in 2020
Figure 14. Global Top Treatment for Genito-Urinary Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment for Genito-Urinary as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Treatment for Genito-Urinary Revenue in 2020
Figure 16. Global Treatment for Genito-Urinary Revenue Market Share by Type (2016-2021)
Figure 17. Global Treatment for Genito-Urinary Revenue Market Share by Type (2022-2027)
Figure 18. North America Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Treatment for Genito-Urinary Market Share by Type (2016-2027)
Figure 20. North America Treatment for Genito-Urinary Market Share by Application (2016-2027)
Figure 21. North America Treatment for Genito-Urinary Market Share by Country (2016-2027)
Figure 22. United States Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Treatment for Genito-Urinary Market Share by Type (2016-2027)
Figure 26. Europe Treatment for Genito-Urinary Market Share by Application (2016-2027)
Figure 27. Europe Treatment for Genito-Urinary Market Share by Country (2016-2027)
Figure 28. Germany Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Treatment for Genito-Urinary Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Treatment for Genito-Urinary Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Treatment for Genito-Urinary Market Share by Region (2016-2027)
Figure 38. China Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Treatment for Genito-Urinary Market Share by Type (2016-2027)
Figure 46. Latin America Treatment for Genito-Urinary Market Share by Application (2016-2027)
Figure 47. Latin America Treatment for Genito-Urinary Market Share by Country (2016-2027)
Figure 48. Mexico Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Treatment for Genito-Urinary Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Treatment for Genito-Urinary Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Treatment for Genito-Urinary Market Share by Country (2016-2027)
Figure 54. Turkey Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Treatment for Genito-Urinary Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Daiichi Sankyo Company Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 59. Bayer Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Treatment for Genito-Urinary Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

【掲載企業】

Daiichi Sankyo Company、Pfizer、Bayer、Astellas Pharma、Allergan、GSK、Otsuka Pharmaceutical、Sanofi

★調査レポート[世界の泌尿生殖器治療市場規模・現状・予測2021-2027] (コード：QY21APR5739)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の泌尿生殖器治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ

◆関連市場調査レポート◆

世界の尿路感染症治療市場規模・現状・予測2021-2027
QY21APR5835 / QYResearch / 2021年4月 / 本調査資料では、尿路感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（複雑UTI、再発性複雑UTI、単純UTI、神経因性膀胱感染症、その他）、用途別市場規模（病院薬局、婦人科及び泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・尿路感染症治療の市場動向・企業の競争状況、市場シェア・尿路感染症治療の種類別市場規模（複雑UTI、再発性複雑UTI、単純UTI、神経因性膀胱感染症、その他）・尿路感染症治療の用途別市場規模（病院薬局、婦人科及び泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）・尿路感染症治療の北米市場規模2016-2027（アメリカ、カナダ）・尿路感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・尿路感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・尿路感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing prevalence, the number of UTI increases, and thus, the high demand for drugs. Hence, increasing prevalence of diabetes worldwide is expected to act as a major driver for the global urinary tract infection therapeutics market. Market Analysis and Insights: Global Urinary Tract Infection Treatment Market The global Urinary Tract Infection Treatment market size is...

世界の尿中スリング市場規模・現状・予測2021-2027
QY21APR5832 / QYResearch / 2021年4月 / 本調査資料では、尿中スリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（膣スリング、男性スリング）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・尿中スリングの市場動向・企業の競争状況、市場シェア・尿中スリングの種類別市場規模（膣スリング、男性スリング）・尿中スリングの用途別市場規模（病院、診療所、その他）・尿中スリングの北米市場規模2016-2027（アメリカ、カナダ）・尿中スリングの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・尿中スリングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・尿中スリングの中南米市場規模2016-2027（メキシコ、ブラジル）...Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body's tissue or synthetic mesh to create a hammock-like fixture that wraps around the bladder neck and a tube that transports urine from the bladder. Urinary incontinence slings are also called urethral support slings. The rising medical tourism initiatives on a global level is estimated to drive the growth prospects for the global urinary slings market until the end of 2023. It has been observed that governments around the...

世界の尿路感染症治療薬市場規模・現状・予測2021-2027
QY21APR5834 / QYResearch / 2021年4月 / 本調査資料では、尿路感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キノロン、ペニシリン＆組み合わせ、セファロスポリン、テトラサイクリン、スルホンアミド、ニトロフラン、その他）、用途別市場規模（病院薬局、小売薬局、Eコマース）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・尿路感染症治療薬の市場動向・企業の競争状況、市場シェア・尿路感染症治療薬の種類別市場規模（キノロン、ペニシリン＆組み合わせ、セファロスポリン、テトラサイクリン、スルホンアミド、ニトロフラン、その他）・尿路感染症治療薬の用途別市場規模（病院薬局、小売薬局、Eコマース）・尿路感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ）・尿路感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・尿路感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・尿路感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Urinary Tract Infection Therapeutics Market The global Urinary Tract Infection Therapeutics market size is projected to reach US$ 81750 million by 2026, from US$ 71130 million in 2019, at a CAGR of 2.0% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urinary Tract Infection Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urinary Tract Infection...

世界の院内感染性尿路感染症検査市場規模・現状・予測2021-2027
QY21APR2922 / QYResearch / 2021年4月 / 本調査資料では、院内感染性尿路感染症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アッセイキット・消耗品、機器）、用途別市場規模（病院・外来、診断臨床検査室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・院内感染性尿路感染症検査の市場動向・企業の競争状況、市場シェア・院内感染性尿路感染症検査の種類別市場規模（アッセイキット・消耗品、機器）・院内感染性尿路感染症検査の用途別市場規模（病院・外来、診断臨床検査室）・院内感染性尿路感染症検査の北米市場規模2016-2027（アメリカ、カナダ）・院内感染性尿路感染症検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・院内感染性尿路感染症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・院内感染性尿路感染症検査の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Hospital-acquired Urinary Tract Infection Testing Market The global Hospital-acquired Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital-acquired Urinary Tract Infection Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global...

世界の女性用尿失禁製品市場規模・現状・予測2021-2027
QY21APR2335 / QYResearch / 2021年4月 / 本調査資料では、女性用尿失禁製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ストレス性尿失禁、完全尿失禁、真性尿失禁）、用途別市場規模（病院、外来手術センター、婦人科クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・女性用尿失禁製品の市場動向・企業の競争状況、市場シェア・女性用尿失禁製品の種類別市場規模（ストレス性尿失禁、完全尿失禁、真性尿失禁）・女性用尿失禁製品の用途別市場規模（病院、外来手術センター、婦人科クリニック、在宅医療、その他）・女性用尿失禁製品の北米市場規模2016-2027（アメリカ、カナダ）・女性用尿失禁製品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・女性用尿失禁製品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・女性用尿失禁製品の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Female Urinary Incontinence Products Market The global Female Urinary Incontinence Products market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Urinary Incontinence Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Urinary Incontinence...

世界の院内感染性尿路感染症市場規模・現状・予測2021-2027
QY21APR2907 / QYResearch / 2021年4月 / 本調査資料では、院内感染性尿路感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物検査機器、試薬・消耗品、感染予防・監視ソフトウェア）、用途別市場規模（疾病検査、薬剤耐性検査）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・院内感染性尿路感染症の市場動向・企業の競争状況、市場シェア・院内感染性尿路感染症の種類別市場規模（微生物検査機器、試薬・消耗品、感染予防・監視ソフトウェア）・院内感染性尿路感染症の用途別市場規模（疾病検査、薬剤耐性検査）・院内感染性尿路感染症の北米市場規模2016-2027（アメリカ、カナダ）・院内感染性尿路感染症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・院内感染性尿路感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・院内感染性尿路感染症の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Urinary Tract Infection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global...

世界の尿路感染症（UTI）市場規模・現状・予測2021-2027
QY21APR5833 / QYResearch / 2021年4月 / 本調査資料では、尿路感染症（UTI）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（上部尿路感染症、下部尿路感染症）、用途別市場規模（病院、診療所、自己管理、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・尿路感染症（UTI）の市場動向・企業の競争状況、市場シェア・尿路感染症（UTI）の種類別市場規模（上部尿路感染症、下部尿路感染症）・尿路感染症（UTI）の用途別市場規模（病院、診療所、自己管理、その他）・尿路感染症（UTI）の北米市場規模2016-2027（アメリカ、カナダ）・尿路感染症（UTI）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・尿路感染症（UTI）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・尿路感染症（UTI）の中南米市場規模2016-2027（メキシコ、ブラジル）...Urinary tract infection (UTI), is an infectious disease caused by the growth and proliferation of pathogens in the urinary tract.Pathogens may include bacteria, mycoplasma, chlamydia, viruses, etc.Urinary tract infection is the second most common infectious disease after respiratory tract infection.Shock deaths from urinary tract infections were the third leading cause of death. Market Analysis and Insights: Global Urinary Tract Infection (UTI) Market The global Urinary Tract Infection (UTI) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測2021-2027
QY21APR5520 / QYResearch / 2021年4月 / 本調査資料では、スウェーデンポルフィリン症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・スウェーデンポルフィリン症治療の市場動向・企業の競争状況、市場シェア・スウェーデンポルフィリン症治療の種類別市場規模（350mg、313mg）・スウェーデンポルフィリン症治療の用途別市場規模（病院、薬局）・スウェーデンポルフィリン症治療の北米市場規模2016-2027（アメリカ、カナダ）・スウェーデンポルフィリン症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・スウェーデンポルフィリン症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・スウェーデンポルフィリン症治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Treatment Market The global Swedish Porphyria Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Swedish Porphyria Treatment market to help players in achieving a strong market position. Buyers of...

世界の後天性血友病A治療市場規模・現状・予測2021-2027
QY21APR0029 / QYResearch / 2021年4月 / 本調査資料では、後天性血友病A治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・後天性血友病A治療の市場動向・企業の競争状況、市場シェア・後天性血友病A治療の種類別市場規模（200IU、250IU）・後天性血友病A治療の用途別市場規模（病院、薬局）・後天性血友病A治療の北米市場規模2016-2027（アメリカ、カナダ）・後天性血友病A治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・後天性血友病A治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・後天性血友病A治療の中南米市場規模2016-2027（メキシコ、ブラジル）...ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acquired hemophilia A Treatment market to help players in achieving a strong market position....

世界の軟骨無形成症治療市場規模・現状・予測2021-2027
QY21APR0013 / QYResearch / 2021年4月 / 本調査資料では、軟骨無形成症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。・市場概要・軟骨無形成症治療の市場動向・企業の競争状況、市場シェア・軟骨無形成症治療の種類別市場規模（RBM-007、TA-46、B-701、その他）・軟骨無形成症治療の用途別市場規模（病院、クリニック、その他）・軟骨無形成症治療の北米市場規模2016-2027（アメリカ、カナダ）・軟骨無形成症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）・軟骨無形成症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）・軟骨無形成症治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Achondroplasia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Achondroplasia Treatment market in terms of revenue. On the...

◆H&Iグローバルリサーチのお客様（例）◆

世界の市場調査レポート

世界の泌尿生殖器治療市場規模・現状・予測2021-2027

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp